Last updated on May 2020

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis


Brief description of study

The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the treatment of candidemia and/or invasive candidiasis when compared to caspofungin (followed by optional oral fluconazole).

Detailed Study Description

A Phase 3, multicenter, prospective, randomized, double-blind, efficacy and safety study of Rezafungin for Injection versus an active comparator regimen of caspofungin followed by optional oral fluconazole step-down therapy in subjects with candidemia and/or invasive candidiasis.

Clinical Study Identifier: NCT03667690

Find a site near you

Start Over

Royal Melbourne Hospital (RMH)

Parkville, Australia
3.22miles
  Connect »

Peter MacCallum Cancer Centre

Melbourne, Australia
5.38miles
  Connect »

Alfred Health

Melbourne, Australia
6.74miles
  Connect »